|
|
Life Science
|
|
Biotechnology & Pharmaceuticals
|
|
The collaboration of these two markets is continuing. Drug discovery, and its eventual development into viable therapeutics, is the goal of most early stage firms, as well as, large pharmaceutical companies. Leveraging business development relationships with large pharmaceutical companies can only enhance such goals and provide the patients with appropriate therapeutics in a timely manner at improving costs.
Companies that can provide the drug discovery tools and services necessary to improve the discovery and development process will be important to this continuum of product development. The consumer will benefit with improved technologies, as it will speed the time to market. Finding the talent to address the regulatory, operational and commercial aspects of this industry is our expertise.
Practice Leaders:
John Baker - Boston
Supriya Dikshit - Mumbai
Sue Rossiter - St. Albans
John Spencer - San Francisco
Consultants:
Paul Bulteel - London
Clare Cizek - Minneapolis
Diane Coletti - Boston
Eric Dieny - Shanghai
Caroline Edwards - Hong Kong**
Boyd Falconer - Ann Arbor
Jeffrey Golove - New York
Rives Hewitt - Toronto
Sussannah Kelly - Toronto
Donald Kilinski - New York
Bertrand Kimper - New York
Victor Kleinman - Palm Beach
Kelvin Ling - Hong Kong**
Linda Madrid - Washington, DC
James Martin - Washington, DC
Tara McKernan - Stamford
Mike Nagata - Tokyo
Yen Pin Ng - Singapore
Bonnie Sharps - Philadelphia
Johannes Suciu - Frankfurt
Naomi Tachibana - Tokyo
Phoebe Wan - Hong Kong**
Jeffrey Webb - St. Albans
Jan Westerink - Amsterdam**
Lance Winn - Austin
Shawn Woessner - Minneapolis
|
|